Pharmacology and regulatory science foresee drug development

被引：0
|
作者：
Tsukamoto, Katsura [1 ]
机构：
[1] Gifu Pharmaceut Univ, Global Regulatory Sci, Gifu, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2015年 / 128卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
AS3-1
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [21] Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes
    Caplan, Michael S.
    Underwood, Mark A.
    Modi, Neena
    Patel, Ravi
    Gordon, Phillip V.
    Sylvester, Karl G.
    McElroy, Steven
    Manzoni, Paolo
    Gephart, Sheila
    Chwals, Walter J.
    Turner, Mark A.
    Davis, Jonathan M.
    Allen, Marilee
    Baer, Gerri
    Besner, Gail
    Canvasser, Jennifer
    Chaaban, Hala
    Clay, Robert
    Connolly, Eamonn
    Davis, Jonathan M.
    Duchon, Jennifer
    Eklund, Wakako
    Ferguson, Joanne
    Gadepalli, Samir
    Good, Misty
    Grogan, Cristal
    Hudson, Lynn
    Khashu, Minesh
    Kim, Jae
    Lotze, Andrea
    Mangili, Alexandra
    Markel, Troy
    Martin, Laura
    Miyazawa, Tokuo
    Neu, Josef
    Noel, Gary
    Portman, Ron
    Rosito, Simone
    Schwartz, Ann
    Scottoline, Brian
    Seo, Suna
    Stromberg, Staffan
    Treem, William
    Umberger, Erin
    Warren, Tracy
    West, Alicia
    JOURNAL OF PEDIATRICS, 2019, 212 : 208 - +
  • [22] Regulatory science for new drug development and pharmacological research: Industry perspective
    Kobayashi, Kazumichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S14 - S14
  • [23] Clinical Pharmacology in Drug Development
    Greenblatt, David J.
    Kern, Barbara A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (01): : 3 - 3
  • [24] Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science
    Zhang, Chen
    Hong, Huixiao
    Mendrick, Donna L.
    Tang, Yun
    Cheng, Feixiong
    BIOMARKERS IN MEDICINE, 2015, 9 (11) : 1241 - 1252
  • [25] Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
    Siler, Scott Q.
    PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1789 - 1802
  • [26] Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends
    Liu, Qi
    Ahadpour, Mitra
    Rocca, Mitra
    Huang, Shiew-Mei
    AAPS JOURNAL, 2021, 23 (03):
  • [27] Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
    Scott Q. Siler
    Pharmaceutical Research, 2022, 39 : 1789 - 1802
  • [28] Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends
    Qi Liu
    Mitra Ahadpour
    Mitra Rocca
    Shiew-Mei Huang
    The AAPS Journal, 23
  • [29] Development and delivery of clinical pharmacology in regulatory agencies
    Breckenridge, Alasdair
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 866 - 869
  • [30] Understanding the Relative Roles of Pharmacogenetics and Ontogeny in Pediatric Drug Development and Regulatory Science
    Leeder, J. Steven
    Kearns, Gregory L.
    Spielberg, Stephen P.
    van den Anker, John
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (12): : 1377 - 1387
12345